Showing 7741-7750 of 19323 results for "".
The Crohn’s & Colitis Foundation's Camp Oasis: A Clinician's Perspective
https://reachmd.com/programs/crohns-colitis-foundation-perspectives/the-crohns-colitis-foundations-camp-oasis-a-clinicians-perspective/10083/Dr. Philip Stein talks with clinicians Dr. Neilanjan Nandi and Susan Peck about their experiences at CCF's Camp Oasis.Decoding Co-Mutations in HR+, HER2- Metastatic Breast Cancer
https://reachmd.com/programs/frontlines-metastatic-breast-cancer/decoding-co-mutations-in-hr-her2-metastatic-breast-cancer/39716/Hormone receptor–positive, HER2-negative (HR+, HER2-) metastatic breast cancer often develops resistance through ESR1 and PIK3CA mutations—but what happens when these alterations occur alone or together? Joining Dr. Charles Turck to break down her research from the 2025 San Antonio Breast Cancer SymMultiple Sclerosis Without Borders: Taking a Global View
https://reachmd.com/programs/neurofrontiers/multiple-sclerosis-without-borders-taking-a-global-view/54237/Multiple sclerosis (MS) is now being recognized as a global disease shaped by a combination of genetics, environment, and social determinants of health—and not one just limited to northern latitudes or people of European descent. However, disparities in awareness, diagnostic resources, and access toUpdates in Undifferentiated Eczema: Taking a Practical Approach to Care
https://reachmd.com/programs/clinicians-roundtable/updates-in-undifferentiated-eczema-taking-a-practical-approach-to-care/32390/Here’s a quick summary of a session on undifferentiated eczema that was presented at the Maui Derm 2025 conference.Advances in DMD Care: Evaluating a Gene Therapy’s Efficacy and Safety
https://reachmd.com/programs/neurofrontiers/advances-in-dmd-care-evaluating-a-gene-therapys-efficacy-and-safety/26327/Explore the efficacy and safety data that led to the expanded approval of a gene therapy for patients with Duchenne muscular dystrophy.Predicting the Development of Food Allergies with Skin Biomarkers
https://reachmd.com/programs/frontlines-food-allergies/predicting-the-development-of-food-allergies-with-skin-biomarkers/18015/Tune in to find out how skin biomarkers can predict the development of food allergies based on findings from a recent study.Clinical Perspective on New Therapies in Resistant Hypertension
https://reachmd.com/clinical-practice/cardiology/clinical-perspective-on-new-therapies-in-resistant-hypertension/48895/How can we best address resistant hypertension in today’s world? New agents address a critical unmet need, and Dr. Yancy has what you need to know.Redefining Non-Small Cell Lung Cancer Care: Updates in Targeted and Perioperative Therapy
https://reachmd.com/programs/deep-breaths-updates-chest/nsclc-targeted-perioperative-therapy/35983/The 2025 European Society for Medical Oncology Congress and World Conference on Lung Cancer revealed significant updates in non-small cell lung cancer care. Learn more as Drs. Gerard Silvestri, Mariam Alexander, and Jessica Donington review new data on EGFR- and ROS1-targeted therapies, perioperativHelping Patients Prioritize Health and Wellness
https://reachmd.com/programs/what-your-patients-are-talking-about/helping-patients-prioritize-health-and-wellness/15488/Why should patients exercise? Tune in.Trimethylamine N-Oxide and CKD: A Concerning Link
https://reachmd.com/programs/clinicians-roundtable/trimethylamine-n-oxide-and-ckd-a-concerning-link/24123/How might trimethylamine N-oxide contribute to the development and progression of CKD? Find out with this recap of a recent study.